TrialClinical and translational science2026

A Phase 1, Open-Label, Randomized Study to Investigate the Pharmacokinetics and Safety of Multiple Doses of Intranasal Naloxone in Healthy Participants.

David Cassie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.